Literature DB >> 10947206

Very high plasma leucine concentrations without neurological symptoms in a patient with classical maple syrup urine disease.

D Skladal1, G Grissenauer, V Konstantopoulou, S Felber, W Sperl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10947206     DOI： 10.1023/a:1005620515996

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.

Authors:  E Treacy; C L Clow; T R Reade; D Chitayat; O A Mamer; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.

Authors:  S R Felber; W Sperl; A Chemelli; C Murr; U Wendel
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

3.  Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.

Authors:  J Korein; C Sansaricq; M Kalmijn; J Honig; B Lange
Journal:  Int J Neurosci       Date:  1994-11       Impact factor: 2.292
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.